Literature DB >> 32547654

A case of a late fatal complication after atrial fibrillation ablation related to a prolonged QT interval unmasked by atrial fibrillation ablation.

Yasuharu Matsunaga-Lee1, Yasuyuki Egami1, Kyosuke Yanagawa1, Hitoshi Nakamura1, Yutaka Matsuhiro1, Koji Yasumoto1, Masaki Tsuda1, Akihiro Tanaka1, Naotaka Okamoto1, Masamichi Yano1, Masaki Yamato1, Ryu Shutta1, Masami Nishino1, Jun Tanouchi1.   

Abstract

A 79-year-old woman with a history of atrial fibrillation (AF) ablation was referred to our hospital for ventricular fibrillation, which was terminated by an automated external defibrillator. The heart rate corrected QT interval was 489 ms. The electrocardiogram monitoring recorded a polymorphic ventricular tachycardia (VT) reproducibly induced by a single morphology premature ventricular contraction (PVC). Therefore, we performed a trigger PVC ablation and implanted an implantable cardioverter defibrillator. No VT events were observed for at least one year after the ablation. A prolonged QT interval after the AF ablation should be carefully noted because it could introduce fatal complications. <Learning objective: A rare late fatal complication of ventricular tachycardia (VT) after atrial fibrillation (AF) ablation can occur even more than one month after the AF ablation. The AF ablation might have an adverse effect on the masked prolonged QT interval. A trigger ablation of the polymorphic VT was helpful to control lethal VTs.>.
© 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Complication; Polymorphic ventricular tachycardia

Year:  2020        PMID: 32547654      PMCID: PMC7283284          DOI: 10.1016/j.jccase.2020.02.007

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  6 in total

1.  Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart--a novel model of isolated Langendorff perfused rabbit heart with intact dual autonomic innervation.

Authors:  G A Ng; K E Brack; J H Coote
Journal:  Exp Physiol       Date:  2001-05       Impact factor: 2.969

2.  Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy.

Authors:  M Kakishita; T Kurita; K Matsuo; A Taguchi; K Suyama; W Shimizu; N Aihara; S Kamakura; F Yamamoto; J Kobayashi; Y Kosakai; T Ohe
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

3.  Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.

Authors:  Dawood Darbar; John Kimbrough; Asif Jawaid; Robert McCray; Marylyn D Ritchie; Dan M Roden
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

4.  Catheter Ablation for Atrial Fibrillation with Heart Failure.

Authors:  Nassir F Marrouche; Johannes Brachmann; Dietrich Andresen; Jürgen Siebels; Lucas Boersma; Luc Jordaens; Béla Merkely; Evgeny Pokushalov; Prashanthan Sanders; Jochen Proff; Heribert Schunkert; Hildegard Christ; Jürgen Vogt; Dietmar Bänsch
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

5.  Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes.

Authors:  Michel Haïssaguerre; Fabrice Extramiana; Mélèze Hocini; Bruno Cauchemez; Pierre Jaïs; Jose Angel Cabrera; Jerónimo Farré; Gerónimo Farre; Antoine Leenhardt; Prashanthan Sanders; Christophe Scavée; Li-Fern Hsu; Rukshen Weerasooriya; Dipen C Shah; Robert Frank; Philippe Maury; Marc Delay; Stéphane Garrigue; Jacques Clémenty
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690

6.  Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation.

Authors:  Yae Min Park; Mi Suk Cha; Woong Chol Kang; Mi-Seung Shin; Young-Hoon Kim; In Suck Choi; Eak Kyun Shin
Journal:  Indian Pacing Electrophysiol J       Date:  2017-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.